Arpegård Johannes, Magnusson Patrik K E, Chen Xu, Ridefelt Peter, Pedersen Nancy L, De Faire Ulf, Svensson Per
Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden Department of Emergency Medicine, Karolinska University Hospital Solna, Stockholm, Sweden
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
J Am Heart Assoc. 2016 Jun 27;5(6):e003085. doi: 10.1161/JAHA.115.003085.
Cystatin C is associated with both renal function and atherosclerotic cardiovascular disease (ASCVD). We have previously shown a genetic correlation between cystatin C and prevalent ASCVD. The objective of this article is to study whether variation in cystatin C or creatinine predicts incident ASCVD when controlled for genetic factors.
The predictive value of cystatin C and creatinine for incident ASCVD was studied in 11 402 Swedish twins, free of CVD at baseline, in an adjusted Cox-regression model during a median follow-up of 71 months. Twin pairs discordant for incident stroke, myocardial infarction and ASCVD during follow-up were identified and within-pair comparisons regarding cystatin C and creatinine levels were performed. We also investigated whether contact frequency and degree of shared environment influences were associated with similarity in cystatin C levels. In univariate analysis, cystatin C predicted incident ASCVD hazard ratio 1.57, 95% CI 1.47-1.67. When adjusted for traditional Framingham risk factors as covariates, cystatin C remained a predictor of incident stroke hazard ratio 1.45, 95% CI (1.25-1.70), ASCVD hazard ratio 1.26, 95% CI (1.13-1.41), and myocardial infarction hazard ratio 1.16, 95% CI (1.01-1.33). In twins discordant for incident stroke, cystatin C at baseline was higher in the twin who experienced a stroke compared to the healthy co-twin (1.11±0.3 mg/L versus 1.06±0.3 mg/L), whereas creatinine was lower in the twin who developed CVD compared to their healthy co-twins (76.1±16.9 μmol/L versus 79.4±20.3 μmol/L).
Variation in cystatin C relates to incident ASCVD and to stroke when adjusted for genetic confounding. In identical twins, cystatin C may be a sensitive marker of early hypertensive end-organ damage and small-vessel disease, whereas creatinine level may reflect nutritional status. The findings in disease-discordant monozygotic twins indicate that unique, possibly preventable, environmental factors are important.
胱抑素C与肾功能及动脉粥样硬化性心血管疾病(ASCVD)均相关。我们之前已表明胱抑素C与现患ASCVD之间存在遗传相关性。本文的目的是研究在控制遗传因素的情况下,胱抑素C或肌酐的变化是否能预测ASCVD的发生。
在11402名瑞典双胞胎中研究了胱抑素C和肌酐对ASCVD发生的预测价值,这些双胞胎在基线时无心血管疾病,在中位随访71个月期间采用校正的Cox回归模型进行分析。识别出随访期间发生中风、心肌梗死和ASCVD不一致的双胞胎对,并对胱抑素C和肌酐水平进行双胞胎对内部比较。我们还研究了接触频率和共享环境影响程度是否与胱抑素C水平的相似性相关。在单变量分析中,胱抑素C预测ASCVD发生的风险比为1.57,95%置信区间为1.47 - 1.67。当将传统的弗雷明汉风险因素作为协变量进行校正后,胱抑素C仍然是中风发生的预测指标,风险比为1.45,95%置信区间为(1.25 - 1.70),ASCVD的风险比为1.26,95%置信区间为(1.13 - 1.41),心肌梗死的风险比为1.16,95%置信区间为(1.01 - 1.33)。在发生中风不一致的双胞胎中,经历中风的双胞胎基线时的胱抑素C水平高于健康的同卵双胞胎(1.11±0.3mg/L对1.06±0.3mg/L),而发生心血管疾病的双胞胎的肌酐水平低于其健康的同卵双胞胎(76.1±16.9μmol/L对79.4±20.3μmol/L)。
校正遗传混杂因素后,胱抑素C的变化与ASCVD的发生及中风相关。在同卵双胞胎中,胱抑素C可能是早期高血压靶器官损害和小血管疾病的敏感标志物,而肌酐水平可能反映营养状况。疾病不一致的单卵双胞胎中的研究结果表明,独特的、可能可预防的环境因素很重要。